{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:09:03Z","timestamp":1791079743287,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T00:00:00Z","timestamp":1362528000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0057346","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T20:46:07Z","timestamp":1362602767000},"page":"e57346","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma"],"prefix":"10.1371","volume":"8","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hui K.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Giroux-Leprieur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh T.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy Q.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Luh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Jablons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/156800910790980232","article-title":"Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets","volume":"10","author":"S Crispi","year":"2010","journal-title":"Current Cancer Drug Targets"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant Pleural Mesothelioma","volume":"27","author":"AS Tsao","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant Mesothelioma: Facts, Myths, and Hypotheses","volume":"227","author":"M Carbone","year":"2012","journal-title":"Journal of Cellular Physiology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/CAD.0b013e328341ccdd","article-title":"Targeted therapies in malignant pleural mesothelioma: a review of clinical studies","volume":"22","author":"L Greillier","year":"2011","journal-title":"Anti-Cancer Drugs"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1349-7006.2009.01336.x","article-title":"Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells","volume":"101","author":"Y Sekido","year":"2009","journal-title":"Cancer Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ctrv.2011.01.001","article-title":"Advances in the biology of malignant pleural mesothelioma","volume":"37","author":"PA Zucali","year":"2011","journal-title":"Cancer Treatment Reviews"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","article-title":"Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma","volume":"18","author":"M Carbone","year":"2012","journal-title":"Clinical Cancer Research"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/pr.109.002329","article-title":"Frequent Deregulations in the Hedgehog Signaling Network and Cross-Talks with the Epidermal Growth Factor Receptor Pathway Involved in Cancer Progression and Targeted Therapies","volume":"62","author":"M Mimeault","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.4161\/cc.6.20.4808","article-title":"Non-canonical activation of GLI transcription factors - Implications for targeted anti-cancer therapy","volume":"6","author":"M Lauth","year":"2007","journal-title":"Cell Cycle"},{"key":"ref10","first-page":"457","article-title":"The Hedgehog pathway as a drug target in cancer therapy","volume":"8","author":"M Lauth","year":"2007","journal-title":"Current Opinion in Investigational Drugs"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1039\/B910196A","article-title":"Small-molecule modulators of the Sonic Hedgehog signaling pathway","volume":"6","author":"BZ Stanton","year":"2009","journal-title":"Molecular Biosystems"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrc3079","article-title":"The Hedgehog\u2019s tale: developing strategies for targeting cancer","volume":"11","author":"JMY Ng","year":"2011","journal-title":"Nature Reviews Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-10-2745","article-title":"Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors","volume":"17","author":"PM LoRusso","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma","volume":"366","author":"A Sekulic","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrd3753","article-title":"Vismodegib","volume":"11","author":"A Dlugosz","year":"2012","journal-title":"Nature Reviews Drug Discovery"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.1882","article-title":"Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development","volume":"208","author":"U Tostar","year":"2006","journal-title":"Journal of Pathology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.3563490","article-title":"Identification of an amplified, highly expressed gene in a human glioma","volume":"236","author":"KW Kinzler","year":"1987","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2005.11.036","article-title":"Activation of the hedgehog pathway in a subset of lung cancers","volume":"244","author":"SM Chi","year":"2006","journal-title":"Cancer Letters"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","article-title":"Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations","volume":"24","author":"MC Thompson","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature02009","article-title":"Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis","volume":"425","author":"SP Thayer","year":"2003","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng916","article-title":"Mutations in SUFU predispose to medulloblastoma","volume":"31","author":"MD Taylor","year":"2002","journal-title":"Nature Genetics"},{"key":"ref22","unstructured":"Hui CC, Angers S (2011) Gli Proteins in Development and Disease. Annual Review of Cell and Developmental Biology, Vol 27. Palo Alto: Annual Reviews. 513\u2013537."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.0022-202X.2004.23590.x","article-title":"Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCaT keratinocytes","volume":"124","author":"RLH Bigelow","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"key":"ref24","first-page":"S85","article-title":"Cloning Of The Human Gli2 Promoter: Transcriptional Activation By Tgf-Beta In Keratinocytes Via Smad3\/beta-Catenin Cooperation","volume":"129","author":"S Dennler","year":"2009","journal-title":"Journal of Investigative Dermatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1038\/sj.onc.1208928","article-title":"Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis","volume":"24","author":"D Javelaud","year":"2005","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"14048","DOI":"10.1074\/jbc.M611089200","article-title":"Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells","volume":"282","author":"ZY Ji","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1128\/MCB.02317-05","article-title":"Selective modulation of hedgehog\/GLI target gene expression by epidermal growth factor signaling in human keratinocytes","volume":"26","author":"M Kasper","year":"2006","journal-title":"Molecular and Cellular Biology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/0008-5472.CAN-05-2539","article-title":"Protein kinase C-delta and mitogen-activated protein\/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling","volume":"66","author":"NA Riobo","year":"2006","journal-title":"Cancer Research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1073\/pnas.0504337103","article-title":"Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling","volume":"103","author":"NA Riobo","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mc.20516","article-title":"Regulation of the Hedgehog Signaling by the Mitogen-Activated Protein Kinase Cascade in Gastric Cancer","volume":"48","author":"M Seto","year":"2009","journal-title":"Molecular Carcinogenesis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nrc1208","article-title":"Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer","volume":"3","author":"PM Siegel","year":"2003","journal-title":"Nature Reviews Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.0700776104","article-title":"Melanomas require HEDGEHOG-GLI signaling reaulated by interactions between GLI1 and the RAS-MEK\/AKT pathways","volume":"104","author":"B Stecca","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref33","unstructured":"He B NF, Liang Y, Xu Z, Jablons DM (2010) Targeting GLI proteins in human cancer by small molecules. United States patent US 6,885,550."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-pharmtox-010510-100558","article-title":"Drugging the Cancer Stem Cell Compartment: Lessons Learned from the Hedgehog and Wnt Signal Transduction Pathways","volume":"2011","author":"ME Dodge","year":"2011","journal-title":"Annual Review of Pharmacology and Toxicology, Vol 51"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1158\/1078-0432.CCR-12-0599","article-title":"Role of Hedgehog Signaling in Malignant Pleural Mesothelioma","volume":"18","author":"Y Shi","year":"2012","journal-title":"Clinical Cancer Research"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0057346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:27:29Z","timestamp":1540322849000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0057346"}},"subtitle":[],"editor":[{"given":"Jingwu","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,6]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0057346","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,6]]}}}